Onderneming Jiangsu Aidea Pharmaceutical Co., Ltd.
Aandelen
688488
CNE1000041S6
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
14,78 CNY | -1,66% | -3,40% | +18,15% |
Vakgebied
Aantal werknemers: 476
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Crude Urokinase
43,0
%
| 103 | 42,3 % | 177 | 43,0 % | +71,46% |
Ulinastatin Crude
19,3
%
| 40 | 16,4 % | 80 | 19,3 % | +98,15% |
Senna Granules
15,6
%
| 50 | 20,3 % | 64 | 15,6 % | +29,63% |
New HIV Drug (Enomitide Tablets)
11,9
%
| - | - | 49 | 11,9 % | - |
New HIV Drug (EnovirineTablets)
6,0
%
| 33 | 13,7 % | 25 | 6,0 % | -26,15% |
HIV Diagnostic Reagents
1,8
%
| 12 | 5,0 % | 7 | 1,8 % | -40,95% |
Bacillus Cereus Tablets
1,0
%
| 3 | 1,4 % | 4 | 1,0 % | +19,19% |
Other Crude Human Protein
0,8
%
| 0 | 0,0 % | 3 | 0,8 % | +6.509,67% |
Other Business
0,6
%
| 1 | 0,6 % | 2 | 0,6 % | +69,38% |
Other Generic Drugs
0,0
%
| 0 | 0,0 % | 0 | 0,0 % | -997,00% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 244 | 100,0 % | 411 | 100,0 % | +68,44% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jie Zhang
CEO | Chief Executive Officer | 54 | - |
Chuanhong Zhu
DFI | Director of Finance/CFO | 53 | 16-09-23 |
He Liang Fu
CHM | Chairman | 63 | 01-01-14 |
Qi Hong
CTO | Chief Tech/Sci/R&D Officer | 61 | 19-01-21 |
Jun Wang
COO | Chief Operating Officer | 50 | 01-01-14 |
Guang Rong Wang
BRD | Director/Board Member | 48 | 01-01-15 |
Wei Xuan Zhou
IRC | Investor Relations Contact | 34 | 01-08-20 |
Yan Liu
SEC | Corporate Secretary | 42 | 14-03-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
He Liang Fu
CHM | Chairman | 63 | 01-01-14 |
Guang Ji Wang
BRD | Director/Board Member | 71 | 09-05-19 |
Xiao Yan Qi
BRD | Director/Board Member | 61 | 10-03-22 |
Guang Rong Wang
BRD | Director/Board Member | 48 | 01-01-15 |
Jun Wang
COO | Chief Operating Officer | 50 | 01-01-14 |
Heng Yu
CHM | Chairman | 44 | 01-12-09 |
Feng Ying He
BRD | Director/Board Member | 41 | 01-12-14 |
Zijian Guo
BRD | Director/Board Member | 63 | 15-09-23 |
Jie Zhang
CEO | Chief Executive Officer | 54 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 420 782 808 | 185 754 481 ( 44,14 %) | 0 | 44,14 % |
Bedrijfsgegevens
Jiangsu Aidea Pharmaceutical Co., Ltd.
No.69 New Ganquan West Road Hanjiang District
225008, Yangzhou
+
http://www.aidea.com.cnSector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,15% | 874 mln. | |
-3,45% | 87,17 mld. | |
+2,76% | 40,1 mld. | |
-16,98% | 31,38 mld. | |
+57,86% | 25,12 mld. | |
-16,24% | 15,59 mld. | |
-9,12% | 12 mld. | |
-42,56% | 11,8 mld. | |
-17,10% | 11,8 mld. | |
+6,89% | 8,81 mld. |
- Beurs
- Aandelen
- Koers 688488
- Onderneming Jiangsu Aidea Pharmaceutical Co., Ltd.